Sepul Bio begins clinical trial of ultevursen for USH2A-associated RP
Sepul Bio begins clinical trial of ultevursen for USH2A-associated RP
Search results
Sepul Bio begins clinical trial of ultevursen for USH2A-associated RP
The collective partnership of eight of the leading charities in the sight loss sector, known for the last three years as the VI Charity Sector Partnership, has re-launched under a new identity of the ‘Vision Partnership’ with a re-invigorated purpose and new strategic focus.
We can provide all the support your organisation needs to work with us; from ideas to practical support and materials. The Retina UK team will help your contribution be as fun and rewarding as possible.
In August 2025, 8-year-old Rose Earnshaw is taking on a challenge like no other – completing 5 laps of her local village park (1 mile) every day throughout the month of August, in support of Retina UK’s vital work.
Please read our conditions of use carefully as by using the website you will be assumed to have agreed to be bound by them.
The latest podcast from Retina UK.
A recently published study has provided the first molecular map of the mutation-specific changes that occur in the retina which lead to Congenital Stationary Night Blindness.
Steve is a Paralympian who was diagnosed with retinitis pigmentosa (RP) in 2011.
Retina UK invites expressions of interest for their inaugural career development grant call, which will result in an award of up to £1million as a strategic and targeted investment to result in a transformative impact for therapy for inherited retinal dystrophy.
Skydiving is an exhilarating experience, and you can do this while supporting our cause. Various dates and locations are available across the UK.